Conference on ‘Drugs for the Future: Infectious Diseases’ kickstarts at NIPER, Hyderabad
Saw participation from 450 delegatesA conference on 'Drugs for the Future: Infectious Diseases' is being held at National…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Archive
StemCyte India Therapeutics to expand its operations in India by opening new collection centres
To build 5,000 plus public inventory of UCB units StemCyte India Therapeutics, a unit of StemCyte USA plans to expand its…
Piramal Enterprises receives GLP compliance certificate from NGCMA
The R&D facility in Goregaon, Mumbai is engaged in drug discovery and development of NCE in the area of oncology and metabolic…
Lupin acquires stake in Laboratorios Grin, Mexico
The acquisition marks Lupin’s foray into the high growth Mexican and the larger Latin American pharmaceuticals market Lupin has…
University of Greifswald in collaboration with Polyclone
To engineer transaminase enzymes in order to broaden the substrate scope
Merck initiates phase III fertility study with pergoveris in poor ovarian response patients
The ESPART phase III clinical study focuses on patients that respond poorly to attempts at ovarian stimulation
Dr Reddy’s launches amlodipine besylate and atorvastatin calcium tablets
Are available in bottle counts of 30 and 90
Project Management Institute will conduct PMP exam preparation workshop in Mumbai
Workshop will be conducted by trainers who are practitioners of project management
Program Committee members of COMSOL Conference 2014 call for research papers
Selected papers, posters, and presentations will be featured at the 10th annual COMSOL Conference to be held in Boston from…
Anders Malm appointed as Managing Director at Ecron Acunova
Malm will assume the responsibility for operations of Europe and North America
Clinical trials in India Uncertainty lingers
As the Indian clinical research industry strives to adhere to the numerous changes announced last year, the delay in clearing up…
Clinical trials: Perception vs reality
As regulators and industry hammer out practical implementation strategies of India's evolving clinical trial regulations, both…
Harnessing Asia’s clinical trial potential
Lisa Marie Saldanha, Director, Head of Site Identification Services Asia, Quintiles and Dr Karen Wai, Senior Director, Head, Site…
India, China and other emerging markets key prospects for interventional cardiac device…
Report says that manufacturers must expand capabilities and capacity through strategic partnerships in order to fulfill demand
Suven Life Sciences secures two product patents for their NCEs in the US
Will help in the treatment of disorders associated with neurodegenerative diseases
IDRI and Jubilant Chemsys extend research for TB drug discovery
The additional grant of $3.4 million will enable development of new drugs to combat tuberculosis
US FDA approves Piramal Imaging’s Neuraceq
Will help in PET imaging of beta-amyloid neuritic plaques in the brain
Urgent action needed to prevent unregulated sale of TB drugs in India: MSF
Strict regulation of first-line TB drug formulations and prescription practices in the private sector is needed in India
Novartis bags approval of Xolair
Xolair is the first and only licensed therapy in the US for the nearly 50 per cent of patients with CIU
Glenmark receives $4 million through Swiss subsidiary
Glenmark Pharmaceuticals has informed the Bombay Stock Exchange that the company through its Swiss subsidiary has received $4…